Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.104EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.103EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HC.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.94EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.22.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.109EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCWEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JS.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HG.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCQEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.41.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.119.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122.6 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used